mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for MYLIP
Gene summary
Basic gene Info.Gene symbolMYLIP
Gene namemyosin regulatory light chain interacting protein
SynonymsIDOL|MIR
CytomapUCSC genome browser: 6p23-p22.3
Type of geneprotein-coding
RefGenesNM_013262.3,
DescriptionE3 ubiquitin ligase-inducible degrader of the low density lipoprotein receptorE3 ubiquitin-protein ligase MYLIPband 4.1 superfamily member BZF1cellular modulator of immune recognition (c-MIR)inducible degrader of the LDL-receptormyosin regulatory lig
Modification date20141207
dbXrefs MIM : 610082
HGNC : HGNC
Ensembl : ENSG00000007944
HPRD : 17621
Vega : OTTHUMG00000016405
ProteinUniProt: Q8WY64
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_MYLIP
BioGPS: 29116
PathwayNCI Pathway Interaction Database: MYLIP
KEGG: MYLIP
REACTOME: MYLIP
Pathway Commons: MYLIP
ContextiHOP: MYLIP
ligand binding site mutation search in PubMed: MYLIP
UCL Cancer Institute: MYLIP
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0016567protein ubiquitination14550572


Top
Ligand binding site mutations for MYLIP
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
C387M388TLUSC1
C390C391FOV1
C402P401SSKCM1
C411A413TSTAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for MYLIP
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
C387M388T-1.2464559
C402P401S-1.2057399
C390C391F-0.17528736
C411A413T-0.063314943
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for MYLIP from PDB

Top
Differential gene expression and gene-gene network for MYLIP
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of MYLIP and the right PPI network was created from samples without mutations in the LBS of MYLIP. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for MYLIP
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0014175Endometriosis1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for MYLIP
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of MYLIP go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
ZNZINC(2+)2yhnAC387 C390 C411
ZNZINC(2+)2yhnBC387 C390 C411
ZNZINC(2+)2yhoAC387 C390 C411
ZNZINC(2+)2yhoCC387 C390 C411
ZNZINC(2+)2yhoEC387 C390 C411
ZNZINC(2+)2yhoGC387 C390 C411
ZNZINC(2+)2yhnAC402
ZNZINC(2+)2yhnBC402
ZNZINC(2+)2yhoAC402
ZNZINC(2+)2yhoCC402
ZNZINC(2+)2yhoEC402
ZNZINC(2+)2yhoGC402


Top
Conservation information for LBS of MYLIP
Multiple alignments for Q8WY64 in multiple species
LBSAA sequence# speciesSpecies
C387KEAMLCMVCCE2Homo sapiens, Rattus norvegicus
C387REALLCMLCCE1Danio rerio
C387KEAMLCMACCE1Mus musculus
C390MLCMVCCEEEI2Homo sapiens, Rattus norvegicus
C390LLCMLCCEEEI1Danio rerio
C390MLCMACCEEEI1Mus musculus
C402STFCPCGHTVC3Homo sapiens, Mus musculus, Rattus norvegicus
C402AAFCPCGHMVC1Danio rerio
C408GHTVCCESCAA3Homo sapiens, Mus musculus, Rattus norvegicus
C408GHMVCCQNCAA1Danio rerio
C411VCCESCAAQLQ3Homo sapiens, Mus musculus, Rattus norvegicus
C411VCCQNCAAQLQ1Danio rerio
C418AQLQSCPVCRS4Homo sapiens, Danio rerio, Mus musculus, Rattus norvegicus
C421QSCPVCRSRVE3Homo sapiens, Mus musculus, Rattus norvegicus
C421QSCPVCRSEVE1Danio rerio
H404FCPCGHTVCCE3Homo sapiens, Mus musculus, Rattus norvegicus
H404FCPCGHMVCCQ1Danio rerio


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas